| William M Dougherty, MD | |
|
600 Gresham Dr Ste 1100, Norfolk, VA 23507-1904 | |
| (757) 388-6200 | |
| (757) 388-6201 |
| Full Name | William M Dougherty |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 11 Years |
| Location | 600 Gresham Dr Ste 1100, Norfolk, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174968440 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | 0101267145 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Evms Academic Physicians And Surgeons Health Services Foundation | 5698675510 | 187 |
News Archive
A study in the Jan. 1 issue of the journal Sleep demonstrates that the frequent arousals from sleep that occur in heart failure patients with central sleep apnea (CSA) may reflect the presence of another underlying arousal disorder rather than being a defensive mechanism to terminate apneas.
Hookah waterpipe use has grown in popularity in recent years – 1 in 5 college students in the U.S. and Europe have tried it – but the practice could be more dangerous than other forms of smoking, according to a first-of-its-kind study by researchers at the University of California, Irvine, published recently in Aerosol Science and Technology.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Research conducted by scientists at the Cancer Institute has revealed that drinking two units of alcohol on a daily basis significantly increases the risks of developing breast, bowel, throat and mouth cancer.
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.
› Verified 8 days ago
| Entity Name | Evms Academic Physicians And Surgeons Health Services Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003887118 PECOS PAC ID: 5698675510 Enrollment ID: O20040304001377 |
News Archive
A study in the Jan. 1 issue of the journal Sleep demonstrates that the frequent arousals from sleep that occur in heart failure patients with central sleep apnea (CSA) may reflect the presence of another underlying arousal disorder rather than being a defensive mechanism to terminate apneas.
Hookah waterpipe use has grown in popularity in recent years – 1 in 5 college students in the U.S. and Europe have tried it – but the practice could be more dangerous than other forms of smoking, according to a first-of-its-kind study by researchers at the University of California, Irvine, published recently in Aerosol Science and Technology.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Research conducted by scientists at the Cancer Institute has revealed that drinking two units of alcohol on a daily basis significantly increases the risks of developing breast, bowel, throat and mouth cancer.
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.
› Verified 8 days ago
| Entity Name | Childrens Specialty Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255354130 PECOS PAC ID: 5890788764 Enrollment ID: O20040406001195 |
News Archive
A study in the Jan. 1 issue of the journal Sleep demonstrates that the frequent arousals from sleep that occur in heart failure patients with central sleep apnea (CSA) may reflect the presence of another underlying arousal disorder rather than being a defensive mechanism to terminate apneas.
Hookah waterpipe use has grown in popularity in recent years – 1 in 5 college students in the U.S. and Europe have tried it – but the practice could be more dangerous than other forms of smoking, according to a first-of-its-kind study by researchers at the University of California, Irvine, published recently in Aerosol Science and Technology.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Research conducted by scientists at the Cancer Institute has revealed that drinking two units of alcohol on a daily basis significantly increases the risks of developing breast, bowel, throat and mouth cancer.
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William M Dougherty, MD Po Box 936, Norfolk, VA 23501-0936 Ph: (757) 388-6200 | William M Dougherty, MD 600 Gresham Dr Ste 1100, Norfolk, VA 23507-1904 Ph: (757) 388-6200 |
News Archive
A study in the Jan. 1 issue of the journal Sleep demonstrates that the frequent arousals from sleep that occur in heart failure patients with central sleep apnea (CSA) may reflect the presence of another underlying arousal disorder rather than being a defensive mechanism to terminate apneas.
Hookah waterpipe use has grown in popularity in recent years – 1 in 5 college students in the U.S. and Europe have tried it – but the practice could be more dangerous than other forms of smoking, according to a first-of-its-kind study by researchers at the University of California, Irvine, published recently in Aerosol Science and Technology.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
Research conducted by scientists at the Cancer Institute has revealed that drinking two units of alcohol on a daily basis significantly increases the risks of developing breast, bowel, throat and mouth cancer.
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.
› Verified 8 days ago
Benjamin Joseph Rubinstein, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Ste 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 | |
Dr. Ashley Anders Schroeder, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Ste 1100, Evms Medical Group, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 | |
Eric J Dobratz, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Ste 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 | |
Craig S. Derkay, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-9327 Fax: 757-668-9848 | |
Dr. Stephanie Ann Moody Antonio, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Suite 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 | |
Dr. Kent Kwok Kin Lam, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr Ste 1100, Norfolk, VA 23507 Phone: 757-388-6200 Fax: 757-388-6201 |